Laurus Labs Limited has informed the Exchange about Schedule of meet
LAURUSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Laurus Labs has invited investors and analysts to a conference call to discuss its Q3 and nine-month FY26 results, scheduled for Friday, January 23, 2026 at 5:00 PM IST. The call will be hosted by DAM Capital Advisors and will include an interactive Q&A session. International dial-in numbers are provided for participants from India, Singapore, Hong Kong, the USA, and the UK. Laurus Labs is a Hyderabad-based pharmaceutical and biotech company that reported ₹5,554 crore in revenue for FY2025.
This is a routine procedural filing ahead of the earnings release and is unlikely to move the stock on its own. Investors should look out for the actual Q3 FY26 results, which are typically published a day or two before the conference call.